REGINfo: Lundbeck - Pharmacie - Financial information

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
- Remgro
- RICHEMONT
- RMB Holdings
- Sanlam
- Sasol
- Shoprite
- Standard Bank Group
- Tiger Brands
- Vodacom Group
- WOOLWORTHS
> TA 25
Israel - TA 25
- AVNER OIL
- AZRIELI GROUP
- BEZEQ
- DELEK DRILLIN
- DISCOUNT
- ELBIT SYSTEMS
- FIBI BANK
- GAZIT GLOBE
- ICL
- IFF
- ISRAEL CORP
- KENON
- LEUMI
- MIGDAL INSURANCE
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- OSEM
- PAZ OIL
- PERRIGO
- POALIM
- STRAUSS GROUP
- TEVA

Europe

OMXC 20 NEWS

> FLSmidth & Co.

> GN Store Nord

> Lundbeck

> Novo Nordisk B

> Royal UNIBREW

> Vestas Wind Systems

> William Demant Holding

FEEDS

My Google

Microsoft Live

My Yahoo

COMPANY SEARCH RESULT

$Lundbeck: Click to view the issuer\'s details$

Last update : 16/08/2018 >View issuer details

2019.05.22 | 10:38 | Share History / Voting Rights and Number of Shares

puce Lundbeck increases its share capital by 26,098 shares (0.0131 % of outstanding shares) as a result of exercise of employee warrants - HTML (w)

2019.05.21 | 13:48 | Permanent Information Releases / General Company News

puce Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties - HTML (w)

2019.05.20 | 14:18 | Share History / Voting Rights and Number of Shares

puce Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties - HTML (w)

2019.05.09 | 16:01 | Share History / Voting Rights and Number of Shares

puce Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties - HTML (w)

2019.05.08 | 07:24 | Permanent Information Releases / Sales and Revenues

puce Double-digit growth for all strategic brands and DKK 4,234 million in revenue and DKK 1,200 million in EBIT - HTML (w)

2019.05.08 | Periodic information / 1st Quarter Information

puce Lundbeck : Financial report for the period 1 January to 31 March 2019 - PDF (635Kb)

2019.05.06 | 07:27 | Permanent Information Releases / General Company News

puce Lundbeck to acquire Abide Therapeutics, adding a unique discovery platform and a lead compound in an exploratory phase IIa program for Tourette’s - HTML (w)

2019.03.26 | 14:16 | Annual General Meeting / AGM

puce Lundbeck held its Annual General Meeting on 26 March 2019 at the company’s registered office - HTML (w)

2019.03.08 | 09:00 | Permanent Information Releases / Appointments

puce Lundbeck appoints Keld Flintholm Jørgensen as EVP and Chief Business Officer - HTML (w)

2019.02.28 | 09:15 | Annual General Meeting / Preparatory Documents

puce Notice of Annual General Meeting - HTML (w)

2019.02.18 | 09:46 | Permanent Information Releases / Operations

puce Lundbeck increases its share capital by 5,631 shares (0.0028 % of outstanding shares) as a result of exercise of employee warrants - HTML (w)

2019.02.14 | 15:00 | Permanent Information Releases / General Company News

puce Lundbeck and Otsuka report phase III data evaluating brexpiprazole for the treatment of manic episodes associated with bipolar I disorder - HTML (w)

2019.02.05 | 07:52 | Periodic information / Annual Financial Report

puce Annual Report 2018 for H.Lundbeck A/S - HTML (w)

2019.02.05 | 07:40 | Permanent Information Releases / Sales and Revenues

puce Lundbeck realized 8% growth in revenue (local currencies) and 48% growth in EPS in 2018 - HTML (w)

2019.02.05 | Periodic information / Annual Financial Report

puce Lundbeck : Annual Report 2018 - PDF (3Mb)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 / Doc nb : 97